Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:32 PM
Ignite Modification Date:
2025-12-24 @ 6:32 PM
NCT ID:
NCT02244957
Eligibility Criteria:
Inclusion Criteria:
* Both men and women with age more than 18 years.
* Known diagnosis of stable COPD (GOLD stage 2 or higher) or OSA.
Exclusion Criteria:
* Already using continuous positive airway pressure (CPAP), BPAP device, or nocturnal oxygen.
* Known or suspected renal failure with estimated Glomerular filtration (GFR) \<50 ml/min/1.73 m2 or serum creatinine \> 1.5 mg/dl.
* Chronic atrial fibrillation or frequent premature ventricular contraction (\> 10 beats per hour)
* Women known to be pregnant or planning to be pregnant in next 6 months.
* Known contraindication to MRI: cardiac pacemaker, metallic heart valves, metallic implants, history of claustrophobia.
* If taking sildenafil or related drugs, unable to stop it within 48 hours of the study visit.
* Uncontrolled COPD or acute COPD exacerbation.
* Unstable cardiac diseases.
* Known chronic inflammatory diseases like lupus or active infection.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02244957
Study Brief:
Protocol Section:
NCT02244957